Omega-3 Fatty Acids (DHA/EPA) for Mild Cognitive Impairment (MCI)
B Good Evidence At least one randomized trial supports this, with mostly consistent results.Research suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'braincited.com';
const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dmild\u002Dcognitive\u002Dimpairment';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
The Bottom Line
Research suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.
Key Study Findings
Systematic Review
n=3582
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Dose: None
vs: Placebo or control
Outcome: Cognitive function in AD and MCI patients
Effect: None
None
Population: AD and MCI patients aged 50-90 (31 clinical trials)
Randomized Controlled Trial
n=73
12 weeks
Single-blind
Comparing the Efficacy of Combined Intralesional Triamcinolone Acetonide With Topical Calcipotriol Versus Intralesional Triamcinolone Acetonide …
Dose: IL triamcinolone every 4 weeks + calcipotriol twice daily
vs: IL triamcinolone acetonide alone
Outcome: Hair density (regrowth scale)
Effect: None
0.018 (scalp subgroup at wk12)
Population: Patients with scalp and beard alopecia areata (179 patches)
Review
Effects of Dietary Interventions on Cognitive Outcomes.
Dose: None
vs: None
Outcome: Cognitive outcomes (memory, executive function)
Effect: None
None
Population: Aging adults with cognitive impairment (review)
Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None
vs: None
Outcome: None
Effect: None
None
Population: None
Other
Milk Fat Globules: 2024 Updates.
Dose: None
vs: None
Outcome: Inflammatory markers
Effect: None
None
Population: None
Systematic Review
The Role of Omega-3 Fatty Acid Supplementation in Slowing Cognitive Decline Among Elderly Patients With …
Dose: None
vs: None
Outcome: Cognitive function
Effect: None
None
Population: Alzheimer's disease patients
Key Statistics
18
Studies
3200
Participants
↑
Positive
B
Grade
Referenced Papers
European journal of …
2025
8 citations
Nutrients
2025
6 citations
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Systematic Review
International journal of …
2025
2 citations
Journal of cutaneous …
2025
European journal of …
2024
16 citations
Lasers in medical …
2024
10 citations
Healthcare (Basel, Switzerland)
2024
9 citations
Newborn (Clarksville, Md.)
2024
9 citations
Cureus
2024
8 citations
Journal of cosmetic …
2024
1 citations
American family physician
2024
Current opinion in …
2023
58 citations
Nutrition reviews
2023
18 citations
Archives of dermatological …
2023
3 citations
Vitamin Supplementation and Dementia: A Systematic Review.
Systematic Review
Nutrients
2022
76 citations
Brain, behavior, and …
2022
64 citations
European journal of …
2022
63 citations
The American journal …
2022
18 citations
Journal of Ayub …
2022
4 citations
The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.
Review
Journal of clinical …
2021
38 citations
Antioxidants (Basel, Switzerland)
2021
33 citations
Diet enriched in omega-3 fatty acids alleviates olfactory system deficits in APOE4 transgenic mice.
Other
The European journal …
2021
4 citations
The Senior care …
2021
2 citations
Nutrients
2020
72 citations
Journal of cutaneous …
2020
21 citations
Psychiatrike = Psychiatriki
2020
15 citations
Journal of Alzheimer's …
2020
14 citations
FASEB journal : …
2020
8 citations
Omega-3 fatty acids and cognitive decline: a systematic review.
Systematic Review
Nutricion hospitalaria
2019
40 citations
Alzheimer's research & …
2019
29 citations
The journal of …
2018
24 citations
Journal of Alzheimer's …
2018
12 citations
FASEB journal : …
2017
41 citations
Actas espanolas de …
2017
22 citations
FASEB journal : …
2017
21 citations
Current Alzheimer research
2017
7 citations
Journal of Alzheimer's …
2016
128 citations
NeuroImage
2016
118 citations
FP essentials
2016
11 citations
Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis.
Meta-Analysis
Climacteric : the …
2015
92 citations
Journal of Alzheimer's …
2015
8 citations
European journal of …
2014
204 citations
Nutrition (Burbank, Los …
2014
74 citations
Acta clinica Belgica
2014
44 citations
Nutricion hospitalaria
2014
17 citations
Advances in nutrition …
2013
155 citations
Journal of Alzheimer's …
2012
257 citations
Journal of Alzheimer's …
2012
137 citations
Alzheimer disease and …
2011
52 citations
Molecular neurobiology
2010
145 citations
Journal of Alzheimer's …
2010
110 citations
Journal of Alzheimer's …
2010
55 citations
Women's health (London, …
2010
48 citations
JAMA
2009
304 citations
Progress in neuro-psychopharmacology …
2008
388 citations
Alternative medicine review …
2008
Alternative medicine review …
2007
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Commonly Used Dosages
- general:
- 1,000-2,000 mg combined DHA/EPA per day
- cognitivesupport:
- 1,000-1,700 mg/day (optimal dose-response curve)
Upper limit: 3,000 mg/day combined DHA/EPA (FDA GRAS)
Dosages Studied in Research
| Dosage | Duration | Effect | N |
|---|---|---|---|
| None | -- | Mixed | 3582 |
| IL triamcinolone every 4 weeks + calcipotriol twice daily | 12 weeks | Positive | 73 |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| Vitamin D3 vs triamcinolone acetonide | 12 weeks | Positive | 40 |
| None | -- | Positive | -- |
Best taken: With meals containing fat for better absorption
Safety & Side Effects
Reported Side Effects
- ⚠ Fishy aftertaste or burping
- ⚠ Mild gastrointestinal discomfort
- ⚠ Potential increased bleeding time at very high doses
- ⚠ May lower blood pressure slightly
Known Interactions
- ● Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
- ● Blood pressure medications (additive hypotensive effect)
- ● Orlistat (may reduce omega-3 absorption)
Tolerable upper intake: 3,000 mg/day combined DHA/EPA (FDA GRAS)
Always consult your healthcare provider before starting any supplement.
Frequently Asked Questions
Does Omega-3 Fatty Acids (DHA/EPA) help with Mild Cognitive Impairment (MCI)?
Based on 18 studies with 3,200 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (DHA/EPA) may support Mild Cognitive Impairment (MCI) management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Mild Cognitive Impairment (MCI)?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Mild Cognitive Impairment (MCI)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 18 peer-reviewed studies with 3,200 total participants. The overall direction of effect is positive.
Related Evidence
Other ingredients for Mild Cognitive Impairment (MCI)
Omega-3 Fatty Acids (DHA/EPA) for other conditions
References
- [1] Mehmet Kanbay et al.. Eur J Clin Invest. 2025. Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions. doi:10.1111/eci.70045 PubMed
- [2] Judith Charbit et al.. Nutrients. 2025. Effects of Dietary Interventions on Cognitive Outcomes. doi:10.3390/nu17121964 PubMed
- [3] Maria T Bayo Jimenez et al.. Int J Mol Sci. 2025. Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms. doi:10.3390/ijms262110631 PubMed
- [4] Thoyyib Parammal Karat et al.. J Cutan Med Surg. 2025. Comparing the Efficacy of Combined Intralesional Triamcinolone Acetonide With Topical Calcipotriol Versus Intralesional Triamcinolone Acetonide Monotherapy in Scalp and Beard … doi:10.1177/12034754251316303 PubMed
- [5] Jing Chang et al.. Eur J Nutr. 2024. Effects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild cognitive impairment: a meta-analysis of … doi:10.1007/s00394-024-03324-y PubMed
- [6] Eliza Balazic et al.. Lasers Med Sci. 2024. The role of laser and energy-assisted drug delivery in the treatment of alopecia. doi:10.1007/s10103-024-04015-0 PubMed
- [7] Yen-Yun Chang et al.. Healthcare (Basel). 2024. Omega-3 Fatty Acids for Depression in the Elderly and Patients with Dementia: A Systematic Review and Meta-Analysis. doi:10.3390/healthcare12050536 PubMed
- [8] Akhil Maheshwari et al.. Newborn (Clarksville). 2024. Milk Fat Globules: 2024 Updates. doi:10.5005/jp-journals-11002-0085 PubMed
- [9] Gaurav Vijayrao Deshmukh et al.. Cureus. 2024. The Role of Omega-3 Fatty Acid Supplementation in Slowing Cognitive Decline Among Elderly Patients With Alzheimer's Disease: A Systematic Review … doi:10.7759/cureus.73390 PubMed
- [10] Maha H Ragaie et al.. J Cosmet Laser Ther. 2024. Intralesional vitamin D3 versus intralesional triamcinolone acetonoid in patchy alopecia areata: a comparative clinical and dermoscopic study. doi:10.1080/14764172.2024.2389275 PubMed
- [11] Ecler Ercole Jaqua et al.. Am Fam Physician. 2024. Alzheimer Disease: Treatment of Cognitive and Functional Symptoms. PubMed
- [12] Francine K Welty. Curr Opin Lipidol. 2023. Omega-3 fatty acids and cognitive function. doi:10.1097/MOL.0000000000000862 PubMed
- [13] Victoria Andrews et al.. Nutr Rev. 2023. Dietary pattern, food, and nutritional supplement effects on cognitive outcomes in mild cognitive impairment: a systematic review of previous reviews. doi:10.1093/nutrit/nuad013 PubMed
- [14] Azza Mahfouz Abdel Meguid et al.. Arch Dermatol Res. 2023. Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and … doi:10.1007/s00403-023-02565-x PubMed
- [15] Victoria Gil Martínez et al.. Nutrients. 2022. Vitamin Supplementation and Dementia: A Systematic Review. doi:10.3390/nu14051033 PubMed
- [16] Pan-Yen Lin et al.. Brain Behav Immun. 2022. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial. doi:10.1016/j.bbi.2021.10.014 PubMed
- [17] Amy H R Wood et al.. Eur J Nutr. 2022. Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease. doi:10.1007/s00394-021-02655-4 PubMed
- [18] Laure Rouch et al.. Am J Clin Nutr. 2022. Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's disease neuroimaging initiative: cross-sectional and … doi:10.1093/ajcn/nqac236 PubMed
- [19] Faheema Afsar Khan et al.. J Ayub Med Coll Abbottabad. 2022. Comparative Study Between Intralesional Injection Of Platelet Rich Plasma And Intra Lesional Triamcinolone For The Treatment Of Alopecia Areata. doi:10.55519/JAMC-04-10933 PubMed
- [20] John E Lewis et al.. J Clin Transl Res. 2021. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. PubMed
- [21] Janine Mett. Antioxidants (Basel). 2021. The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Deposition, Oxidative Stress and Metabolic Dysfunction Associated with Alzheimer's … doi:10.3390/antiox10121991 PubMed
- [22] Melissa Lessard-Beaudoin et al.. Eur J Neurosci. 2021. Diet enriched in omega-3 fatty acids alleviates olfactory system deficits in APOE4 transgenic mice. doi:10.1111/ejn.15472 PubMed
- [23] Brittany R Block et al.. Sr Care Pharm. 2021. Online Promotion of "Brain Health" Supplements. doi:10.4140/TCP.n.2021.489 PubMed
- [24] Manuela Pennisi et al.. Nutrients. 2020. Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update. doi:10.3390/nu12051389 PubMed
- [25] Priya Kapoor et al.. J Cutan Aesthet Surg. 2020. Comparative Evaluation of Therapeutic Efficacy of Intralesional Injection of Triamcinolone Acetonide versus Intralesional Autologous Platelet-rich Plasma Injection in Alopecia Areata. doi:10.4103/JCAS.JCAS_16_19 PubMed
- [26] V Gkotzamanis et al.. Psychiatriki. 2020. Dietary interventions and cognition: A systematic review of clinical trials. doi:10.22365/jpsych.2020.313.248 PubMed
- [27] Milan Fiala et al.. J Alzheimers Dis. 2020. Omega-3 Fatty Acids Increase Amyloid-β Immunity, Energy, and Circadian Rhythm for Cognitive Protection of Alzheimer's Disease Patients Beyond Cholinesterase Inhibitors. doi:10.3233/JAD-200252 PubMed
- [28] Yik Chai Charles Lau et al.. FASEB J. 2020. Omega-3 fatty acids increase OXPHOS energy for immune therapy of Alzheimer disease patients. doi:10.1096/fj.202000669RR PubMed
- [29] Amelia Martí Del Moral et al.. Nutr Hosp. 2019. Omega-3 fatty acids and cognitive decline: a systematic review. doi:10.20960/nh.02496 PubMed
- [30] Jeffrey Cummings et al.. Alzheimers Res Ther. 2019. Souvenaid in the management of mild cognitive impairment: an expert consensus opinion. doi:10.1186/s13195-019-0528-6 PubMed
- [31] C Schwarz et al.. J Prev Alzheimers Dis. 2018. Effects of Omega-3 Fatty Acids on Resting Cerebral Perfusion in Patients with Mild Cognitive Impairment: A Randomized Controlled Trial. doi:10.14283/jpad.2017.23 PubMed
- [32] Milan Fiala et al.. J Alzheimers Dis. 2018. Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials? doi:10.3233/JAD-170579 PubMed
- [33] Milan Fiala et al.. FASEB J. 2017. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. doi:10.1096/fj.201700065R PubMed
- [34] Javier Olivera-Pueyo et al.. Actas Esp Psiquiatr. 2017. Dietary supplements for cognitive impairment. PubMed
- [35] Henry M Olivera-Perez et al.. FASEB J. 2017. Omega-3 fatty acids increase the unfolded protein response and improve amyloid-β phagocytosis by macrophages of patients with mild cognitive impairment. doi:10.1096/fj.201700290R PubMed
- [36] Christian Knöchel et al.. Curr Alzheimer Res. 2017. Omega-3 Fatty Acids: Repurposing Opportunities for Cognition and Biobehavioral Disturbances in MCI and Dementia. doi:10.2174/1567205013666160602235520 PubMed
- [37] Abderrahim Oulhaj et al.. J Alzheimers Dis. 2016. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. doi:10.3233/JAD-150777 PubMed
- [38] Theresa Köbe et al.. Neuroimage. 2016. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and … doi:10.1016/j.neuroimage.2015.09.050 PubMed
- [39] Timothy E Albertson et al.. FP Essent. 2016. The Changing Drug Culture: Use and Misuse of Cognition-Enhancing Drugs. PubMed
- [40] P Lehert et al.. Climacteric. 2015. Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis. doi:10.3109/13697137.2015.1078106 PubMed
- [41] Milan Fiala et al.. J Alzheimers Dis. 2015. Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment. doi:10.3233/JAD-150367 PubMed
- [42] Ane Otaegui-Arrazola et al.. Eur J Nutr. 2014. Diet, cognition, and Alzheimer's disease: food for thought. doi:10.1007/s00394-013-0561-3 PubMed
- [43] Nathan O'Callaghan et al.. Nutrition. 2014. Telomere shortening in elderly individuals with mild cognitive impairment may be attenuated with ω-3 fatty acid supplementation: a randomized controlled … doi:10.1016/j.nut.2013.09.013 PubMed
- [44] S Engelborghs et al.. Acta Clin Belg. 2014. Rationale and clinical data supporting nutritional intervention in Alzheimer's disease. doi:10.1179/0001551213Z.0000000006 PubMed
- [45] Dan L Waitzberg et al.. Nutr Hosp. 2014. [Contribution of omega-3 fatty acids for memory and cognitive function]. doi:10.3305/nh.2014.30.3.7632 PubMed
- [46] Tommy Cederholm et al.. Adv Nutr. 2013. ω-3 fatty acids in the prevention of cognitive decline in humans. doi:10.3945/an.113.004556 PubMed
- [47] Stephen C Cunnane et al.. J Alzheimers Dis. 2012. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease. doi:10.3233/JAD-2012-110629 PubMed
- [48] Carlijn R Hooijmans et al.. J Alzheimers Dis. 2012. The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a … doi:10.3233/JAD-2011-111217 PubMed
- [49] Gene L Bowman et al.. Alzheimer Dis Assoc Disord. 2011. Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment. doi:10.1097/WAD.0b013e3181f333d6 PubMed
- [50] Sally A Frautschy et al.. Mol Neurobiol. 2010. Why pleiotropic interventions are needed for Alzheimer's disease. doi:10.1007/s12035-010-8137-1 PubMed
- [51] Patrick J G H Kamphuis et al.. J Alzheimers Dis. 2010. Can nutrients prevent or delay onset of Alzheimer's disease? doi:10.3233/JAD-2010-091558 PubMed
- [52] Rosebud O Roberts et al.. J Alzheimers Dis. 2010. Polyunsaturated fatty acids and reduced odds of MCI: the Mayo Clinic Study of Aging. doi:10.3233/JAD-2010-091597 PubMed
- [53] Jennifer G Robinson et al.. Womens Health (Lond). 2010. Omega-3 fatty acids and cognitive function in women. doi:10.2217/whe.09.75 PubMed
- [54] Beth E Snitz et al.. JAMA. 2009. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. doi:10.1001/jama.2009.1913 PubMed
- [55] Chih-Chiang Chiu et al.. Prog Neuropsychopharmacol Biol Psychiatry. 2008. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. doi:10.1016/j.pnpbp.2008.05.015 PubMed
- [56] Parris M Kidd. Altern Med Rev. 2008. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. PubMed
- [57] Parris M Kidd. Altern Med Rev. 2007. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. PubMed
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.